Literature DB >> 20513254

Risk factors for 30-day mortality in patients with carbapenem-resistant Acinetobacter baumannii during an outbreak in an intensive care unit.

C G Prates1, A F Martins, S V Superti, F S Lopes, F Ramos, V V Cantarelli, A P Zavascki.   

Abstract

This study assessed risk factors for 30-day mortality in 66 patients with carbapenem-resistant Acinetobacter baumannii (CRAB) infection or colonization during an outbreak in an intensive-care unit. Clinical and demographic characteristics were evaluated. The overall 30-day mortality was 47·0%. In the multivariate Cox regression model, septic shock [adjusted hazard ratio (aHR) 5·01, 95% confidence interval (CI) 2·32-10·01] and APACHE II score at onset of infection (aHR 1·11, 95% CI 1·04-1·18) were significantly associated with 30-day mortality. Administration of appropriate therapy was a protective factor, but it was not statistically significant (aHR 0·48, 95% CI 0·21-1·12). A sample of isolates tested (n=27) carried the blaOXA-23 gene. Severity of baseline condition and severity of infection presentation were major risk factors for mortality during the outbreak. Patients who received appropriate therapy tended to have lower mortality rates, although therapy was started late and dosage was suboptimal in most cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513254     DOI: 10.1017/S0950268810001238

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  5 in total

1.  Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface-associated motility.

Authors:  Christin N McQueary; Benjamin C Kirkup; Yuanzheng Si; Miriam Barlow; Luis A Actis; David W Craft; Daniel V Zurawski
Journal:  J Microbiol       Date:  2012-06-30       Impact factor: 3.422

2.  Prediction of the Risk of Hospital Deaths in Patients with Hospital-Acquired Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii Infection: A Multi-Center Study.

Authors:  Hongmei Shu; Lijuan Li; Yimin Wang; Yiqun Guo; Chunlei Wang; Chunxia Yang; Li Gu; Bin Cao
Journal:  Infect Drug Resist       Date:  2020-11-19       Impact factor: 4.003

3.  Outcomes of critically ill cancer patients with Acinetobacter baumannii infection.

Authors:  Silvio A Ñamendys-Silva; Paulina Correa-García; Francisco J García-Guillén; María O González-Herrera; Américo Pérez-Alonso; Julia Texcocano-Becerra; Angel Herrera-Gómez; Patricia Cornejo-Juárez; Abelardo Meneses-García
Journal:  World J Crit Care Med       Date:  2015-08-04

4.  The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumannii infection.

Authors:  Erika Ferraz de Gouvêa; Ianick Souto Martins; Marcia Halpern; Adriana Lúcia Pires Ferreira; Samanta Teixeira Basto; Renato Torres Gonçalves; Beatriz Meurer Moreira; Guilherme Santoro-Lopes
Journal:  BMC Infect Dis       Date:  2012-12-13       Impact factor: 3.090

5.  Carbapenem-resistant Acinetobacter ventilator-associated pneumonia: Clinical characteristics and outcome.

Authors:  Mohan Gurjar; Saurabh Saigal; Arvind Kumar Baronia; Bhaskar P Rao; Afzal Azim; Banani Poddar; Ratender Kumar Singh
Journal:  Indian J Crit Care Med       Date:  2013-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.